LEADERSHIP
Executive Committee
Bringing together over 20 years of experience in corporate finance, mergers and acquisitions and strategy consulting, the Executive Committee maintains a high-level strategic vision and direction while being firmly grounded in content expertise and client experience. Their mandate is to consistently bring the highest quality impact to our clients regardless of unique client challenges and market conditions.
Jay Moulton
Jay Moulton has led acquisition and financing activities for numerous private and public companies, spanning many industries, since 1988. During this time, he has completed more than forty transactions as either a principal or on behalf of clients, and has actively represented shareholders’ interests, either as a director or as an advisor to the Board of Directors of 25 different companies. He is a recognized expert in the field of mergers and acquisitions and is often asked to share his expertise at seminars and conferences.
Mr. Moulton has implemented and supervised the full range of acquisition activities from strategic planning, through target identification, negotiation, due diligence, financing, closing and post-closing integration. He is a master matchmaker, highly skilled at structuring and closing often complex deals. Mr. Moulton gains a unique perspective of private companies, by applying his wide-ranging operating, executive, corporate finance, engineering and deal-making experience.
In addition to his corporate finance expertise, Mr. Moulton is also an accomplished operational executive. In 1988, he led a highly successful leveraged buy-out of Plastifab Industries, a leading plastics manufacturer, and served as the company’s President. Prior to Plastifab, he was Vice President of Sales of Metropolitan Funds Ltd., a Metropolitan Life subsidiary, and an engineering coordinator with Fluor Corporation. In all three cases, Mr. Moulton was the youngest executive or manager ever to serve in these positions.
Mr. Moulton has an MBA from Harvard Business School and a Bachelor of Electrical Engineering degree from the Royal Military College of Canada, where he was also commissioned as an officer in the Canadian Armed Forces.
Tony Nimeh, MD
Dr. Tony Nimeh, holds a doctorate in medicine from McGill University and a surgical internship from Harvard Medical School, where he underwent training in urology. In his clinical experience in Boston, Dr. Nimeh managed the medical team as well as the multidisciplinary and interdepartmental activities. He also led the consultation service in urology and executed major surgeries in cooperation with the surgical team. He also published numerous research articles in urology, cardiac surgery, plastic surgery, and ophthalmology.
Following his clinical experience, Dr. Nimeh pursued a career in management consulting with the Boston Consulting Group and held a management position at Grant Thornton’s Healthcare Consulting division. He has advised Fortune 100 companies in the healthcare, technology, and financial services industries, including software companies, top-10 Pharma, biotech and medical devices companies, leading banks, governments, hospitals and non-profit organizations.
His past work includes strategy mandates to improve top-line growth, operational efficiency, and bottom line consolidation. Representative work includes the organizational restructuring of the Canadian subsidiary of a leading global pharmaceutical company, the portfolio development strategy for the European division of a top pharmaceutical company and the implementation of major initiatives to double R&D productivity of a leading pharmaceutical company. He also supported industry groups through pricing negotiations and helped develop the next breakthrough idea to support the healthcare practice leadership. In the public sector, his work included strategic planning and business case analysis for major structural and strategic reorganizations, and process optimizations in hospitals.
As part of his pro-bono activities, he helped develop a private-public partnership network of biomarker research in Toronto and a business strategy for the national scaling of a non-profit educational organization. He also co-hosted the Canadian Summit on Transforming Healthcare Delivery in Toronto.
